Telomir Pharmaceuticals Inc
For the period ended Dec 31, 2024. Filed Feb 4, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 4, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Financial Statements
Our Financial Statements and Notes thereto and the reports of Salberg & Company P.A for year ended December 31, 2024 and Chery Bekaert for the year ended December 31, 2023, our independent registered public accounting firms, for the respective years ended listed above, are set forth on pages F-1 through F-16 of this Report.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.